2月25日，《21辟谣》注意到，有消息称"飞天茅台出厂价由1169元/瓶上调至1299元/瓶"，引发市场关 注。 截至午间收盘，贵州茅台报1504.77元/股，涨2.59%，总市值为1.88万亿元。 （文章来源：21世纪经济报道） 对此，《21辟谣》记者以投资者身份致电贵州茅台，公司接线工作人员回应："如果是飞天有价格有调 整的话，是要披露的重大事项，公司会及时披露信息。网上经常有这种小作文，建议关注公司披露的公 告，没必要去相信网上的这种谣传。" ...

Core Viewpoint - The fertilizer and pesticide sector in A-shares experienced a significant surge, with the Wind Fertilizer and Pesticide Index rising over 4%, while Meibang Co., Ltd. exhibited extreme volatility, showcasing a "heaven and earth board" phenomenon in its stock performance [2][3] Group 1: Stock Performance - Meibang Co., Ltd. opened at the涨停 price but quickly fell to the跌停 price, resulting in a dramatic "heaven and earth board" movement, closing at 28.39 yuan per share with a trading volume exceeding 700 million yuan [2] - The stock has previously shown extreme volatility, including a "heaven and earth board" on January 6, 2025, with a price fluctuation of 20% and a turnover rate exceeding 13% [2] Group 2: Risk Warnings - Meibang Co., Ltd. has issued multiple risk warning announcements, specifically on February 12, 13, and 24, indicating that the stock's price deviation exceeded 20% over three consecutive trading days [3] - The company noted that its stock price increase is not aligned with its operational performance, as it rose 46.43% from February 10 to 24, while the Shanghai Composite Index fell by 0.27% and the agricultural chemical industry only increased by 5.96% during the same period [3] Group 3: Financial Performance - For the first three quarters of 2025, Meibang Co., Ltd. reported a revenue of 609 million yuan, a year-on-year decrease of 2.23%, and a net profit attributable to shareholders of 36.2 million yuan, down 16.36% year-on-year [3] - The company's current rolling price-to-earnings ratio stands at 143.19, significantly higher than the industry average of 33.99, indicating a potential overvaluation [3]

据央视财经，2月25日，香港特区政府财政司司长陈茂波在立法会发表2026至2027财政年度政府财政预 算案。陈茂波表示，为持续优化证券市场，吸引发行人和提升市场效率，港交所将推进以下工作： （一）在第一季就修订"同股不同权"企业上市要求、便利海外发行人第二上市、优化首次公开招股流 程，以及为生物科技和特专科技公司申请上市提供更多弹性等咨询市场； （二）在上半年落实完善结构性产品上市框架，以及就推动"T+1"结算周期的具体实施方案咨询市场； （三）改革证券市场每手买卖单位，以及联同香港证监会和业界在年内推出无纸证券市场制度。 （文章来源：21世纪经济报道） ...

Group 1 - The core viewpoint of the article highlights that multiple jewelry brands, including Chow Tai Fook, are implementing price increases on their products, particularly focusing on fixed-price items, with expected increases ranging from 15% to 30% [1] - Chow Tai Fook is set to initiate a new round of price hikes after the Spring Festival, with the increase expected around March 10 [3] - A specific example includes a gold bracelet weighing 29.88 grams, which is set to rise from 53,800 yuan to 71,800 yuan, indicating an increase of over 33% [3] Group 2 - Other brands such as Baolan and Linchao have also raised prices or announced upcoming price increases, with Baolan and Linchao completing their price adjustments at the end of January and early February, respectively [1] - Lao Pu Gold is also expected to start its first price adjustment after the Spring Festival in three days [1]

Core Viewpoint - Anta Group is accelerating its international expansion, with the opening of its first flagship store in North America located in Beverly Hills, Los Angeles, which signifies a strategic move in its globalization efforts [1][2]. Group 1: Store Opening and Strategy - The Beverly Hills store will operate under a direct sales model, marking Anta's first offline direct store in the U.S., which entails significant operational costs [1]. - Anta's CEO, Xu Yang, stated that the Beverly Hills store is a crucial step in the brand's global strategy, focusing on promoting sports experiences, brand collaborations, and local initiatives to strengthen brand recognition in North America [2]. Group 2: Globalization Strategy - Anta Group has outlined a "three-step" strategy for globalization: 1. Establishing international brands in China, exemplified by building FILA and Descente into billion-yuan brands. 2. Expanding globally through acquisitions, highlighted by the 2019 purchase of Amer Sports. 3. Promoting the Anta brand internationally to become a global player [2]. - The Beverly Hills store is considered an important part of the "World Anta" initiative [3]. Group 3: Acquisition and Market Position - Anta Group announced plans to acquire a 29.06% stake in Puma for €1.505 billion (approximately ¥12.28 billion), making it the largest single shareholder without controlling interest [3]. - The acquisition of Puma is expected to enhance Anta's global operations, leveraging Puma's established market position [4]. Group 4: Market Performance and Future Plans - Domestic market pressures may be accelerating Anta's international expansion, as indicated by a slight decline in retail sales for the Anta brand while FILA experienced mid-single-digit growth [4]. - In contrast, Amer Sports, which operates globally, reported a 28% year-on-year revenue increase to $2.101 billion, suggesting a successful overseas strategy that Anta aims to replicate [4]. - Anta has a clear plan for overseas market expansion, including a thousand-store initiative in Southeast Asia, establishing a subsidiary in the Middle East, and entering major market channels in North America and Europe [4].

Group 1 - The core point of the article is the recent personnel changes at Jaguar Land Rover China, indicating a strategic shift in the luxury automotive sector towards a more aggressive approach in the market [1] - Jaguar Land Rover China's President and CEO, Pan Qing, has been promoted to Global Procurement Director while retaining his role as China President [1] - Tim Howard, the current CFO of Jaguar Land Rover China, will take over as CEO of Jaguar Land Rover China [1] Group 2 - The article highlights a trend of key executive changes in the luxury automotive sector, with BMW and Mercedes-Benz also announcing significant leadership adjustments in their China operations [1] - BMW appointed Christian Ach as the new President and CEO for Greater China at the end of January, following the departure of Gao Xiang [1] - Mercedes-Benz announced the departure of Duan Jianjun and the appointment of Daniel Lescow as the new President and CEO of Beijing Mercedes-Benz Sales Service Co., Ltd. in mid-February [1] Group 3 - The frequent leadership changes among luxury car manufacturers signal a shift from a defensive to an offensive strategy as they prepare for the competitive landscape leading up to 2026 [1]

四、选准就业领域，评估投资风险。不是所有领域都适合外国公民就业，安哥拉《外国公民制度法》第 68条规定，如果拥有能胜任工作的本国劳动力，则不给外国公民签发工作签证。来安哥拉投资项目也不 保证必然获得所需的工作签证。 五、配合执法检查。使馆一直要求安哥拉执法部门文明和规范执法，同时也呼吁在安中国公民配合正常 执法，理性保护自身权益。 六、使馆提供证件服务。如果担心无工作签证被查，及时离开乃是上策。使馆将积极配合中国公民办理 回国证件。请准确理解领事保护和协助涵义，使馆将在职责范围内全力保护合法权益、协助正当需求。 （文章来源：21世纪经济报道） 一段时间以来，安哥拉移民局持续开展打击非法移民行动，包括邻国在内的部分外国公民因非法入境、 居留和就业被拘押、罚款并遣返，亦有少数中国公民因非法居留、没有或滥用工作签证受到相应处罚。 大使馆曾多次提醒在安哥拉的中资企业和公民，遵守包括安哥拉《外国公民制度法》《劳动法》在内的 相关法律，合法就业，守法经营。大使馆也多次就相关问题同安哥拉主管部门沟通，现再次提醒中国企 业和公民，理性看待涉安哥拉工作签证问题。 一、正确理解工作签证。签证是国家主权体现，是维护国家安全、发展、 ...

Market Performance - The Hong Kong stock market reversed its previous decline, with the Hang Seng Index rising by 0.75%, the National Enterprises Index increasing by 0.90%, and the Hang Seng Technology Index up by 0.34% [1]. Sector Performance - The metals sector showed strong performance, with gold and precious metals, general metals, and mining industries leading the gains. Notably, Chongqing Steel, New Mining Resources, and Long Resources saw increases of over 13% [1]. - Real estate stocks strengthened, with Country Garden rising by over 6%, and Longfor Group and China Resources Land both increasing by over 4% [1]. - The software services sector continued to struggle, with MINIMAX-WP dropping by over 11% and Zhiyuan falling by over 5% [1]. Capital Flow - In the early session, southbound funds recorded a net sell of 1.7 billion HKD, with the Shanghai Stock Connect seeing a net sell of 1.883 billion HKD, while the Shenzhen Stock Connect had a net buy of 183 million HKD [1].

Core Viewpoint - Jinko Energy Storage Technology Co., Ltd. has increased its registered capital from 50 million RMB to 550 million RMB, marking a 1000% increase, indicating significant growth and investment in the energy storage sector [1]. Company Information - Jinko Energy Storage Technology Co., Ltd. was established in December 2022 and is wholly owned by Jinko Energy (688223) [1][3]. - The legal representative of the company is Li Xiande, and its business scope includes energy storage technology services, emerging energy technology research and development, and manufacturing and sales of industrial automatic control systems [1][3]. Capital Changes - The registered capital change reflects a substantial increase from 50 million RMB to 550 million RMB, which is a 1000% increase [1][2]. - The capital increase is part of the company's strategy to expand its operations and capabilities in the energy storage market [1].

Group 1 - The core viewpoint of the news is the appointment of Zhang Xue and Li Huiyao as co-heads of the pharmaceutical and biotechnology research team at Guosheng Securities, indicating a strategic move to strengthen their research capabilities in the pharmaceutical sector [1] - Zhang Xue has a Master's degree in Public Health from Peking University and possesses a dual background in medicine and finance, with 8 years of experience in pharmaceutical research, previously working at Chuan Cai Securities, Xinda Securities, and Tianfeng Securities [1] - Li Huiyao holds a PhD in Medicine from Sun Yat-sen University and has 6 years of experience in pharmaceutical research, having worked at Xinda Securities and Tianfeng Securities [1] Group 2 - The recruitment of multiple analysts, including two co-heads for the pharmaceutical sector, reflects Guosheng Securities' commitment to expanding its research team and enhancing its analytical capabilities in the healthcare industry [1] - The article also mentions another analyst, who has a Master's degree in Management from Shanghai Jiao Tong University and 4 years of experience in pharmaceutical research, focusing on traditional Chinese medicine, pharmacies, and distribution [8] - Additionally, a research assistant with a Bachelor's degree in Biotechnology from Wuhan University and a Master's in Biomedical Engineering from the National University of Singapore is part of the team, concentrating on innovative drug research and clinical progress [10]